Page last updated: 2024-12-06

flavodic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

flavodic acid: capillary protective agent; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71944
CHEMBL ID2107394
CHEBI ID135561
SCHEMBL ID867342
MeSH IDM0042568

Synonyms (33)

Synonym
flavodic acid
flavodinsaeure
CHEBI:135561
37470-13-6
D07959
flavodic acid (inn)
2,2'-[(4-oxo-2-phenyl-4h-chromene-5,7-diyl)bis(oxy)]diacetic acid
CHEMBL2107394
AKOS015969769
acido flavodico [inn-spanish]
((4-oxo-2-phenyl-4h-1-benzopyran-5,7-diyl)dioxy)diacetic acid
(4-oxo-2-phenyl-4h-chromen-5,7-diyldioxy)diessigsaeure
acide flavodique
flavodic acid [inn:dcf]
2z9v171uem ,
einecs 253-517-0
unii-2z9v171uem
acide flavodique [inn-french]
acidum flavodicum [inn-latin]
acido flavodico
acidum flavodicum
flavodic acid [dcf:inn]
SCHEMBL867342
STL464576
flavodic acid [who-dd]
flavodic acid [inn]
DTXSID90190909
2-{[5-(carboxymethoxy)-4-oxo-2-phenyl-4h-chromen-7-yl]oxy}acetic acid
SR-01000944817-1
sr-01000944817
eim07-29887
Q27255849
2-[5-(carboxymethoxy)-4-oxo-2-phenylchromen-7-yl]oxyacetic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
flavonesA member of the class of flavonoid with a 2-aryl-1-benzopyran-4-one (2-arylchromen-4-one) skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1072546Cytotoxicity against mouse H22 cells assessed as growth inhibition by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Synthesis and antitumor activity evaluation of chrysin derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-199032 (96.97)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (3.03)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.58 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]